UK markets close in 25 minutes

Grifols, S.A. (0RDV.IL)

IOB - IOB Delayed price. Currency in EUR
Add to watchlist
12.27+0.04 (+0.36%)
As of 4:56PM BST. Market open.
Full screen
Previous close12.23
Bid11.85 x 0
Ask12.38 x 0
Day's range12.19 - 12.27
52-week range11.82 - 16.80
Avg. volume28,518
Market cap11.992B
Beta (5Y monthly)0.10
PE ratio (TTM)12.67
Earnings dateN/A
Forward dividend & yield0.36 (2.98%)
Ex-dividend date03 Jun 2021
1y target estN/A
  • Reuters

    Spain's Grifols to buy rival Biotest for up to $1.9 billion

    MADRID (Reuters) -Spanish pharmaceuticals company Grifols proposed a 1.6 billion euro ($1.9 billion) takeover of its German rival Biotest on Friday, in a move to consolidate the plasma-based drug industry. Grifols said it had agreed with Tiancheng International Investment to buy the Hong Kong-based company's controlling stake in Biotest for 1.1 billion euros. The Barcelona-based company agreed to buy 89.88% of Biotest's ordinary shares that carry voting rights, but which represent only 44.54% of the company's capital, and a further 0.54% of capital in preferred shares that do not carry voting rights, from Hong Kong-based Tiancheng.